Anaplastic astrocytoma (Q44125195)

30 November 2017

title

Anaplastic astrocytoma (English)

1 reference

30 November 2017

Sean A Grimm

1

1 reference

30 November 2017

Thomas J Pfiffner

series ordinal

2

1 reference

30 November 2017

publication date

1 June 2013

1 reference

Current treatment options in neurology

30 November 2017

published in

1 reference

30 November 2017

volume

15

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

302-315

1 reference

Anaplastic astrocytoma in adults.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Neuroimaging in neuro-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Occupational exposure to chlorinated aliphatic hydrocarbons and risk of astrocytic brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Occupational exposure to magnetic fields and the risk of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Primary brain tumours in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Imaging of adult astrocytic brain tumours with 7 T MRI: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Advanced MRI in the management of adult gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

MRI in treatment of adult gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Biology, genetics and imaging of glial cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Genomic Profiles of Glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Malignant astrocytic glioma: genetics, biology, and paths to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

The prognostic IDH1( R132 ) mutation is associated with reduced NADP -dependent IDH activity in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Thromboembolic disease in patients with high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Complications of therapy for venous thromboembolic disease in patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Postoperative Irradiation of Glioblastomas: Results in a Randomized Series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Super fractionation in glioblastoma multiforme-results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Assumptions in the radiotherapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Neurological complications of radiotherapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Somnolence after Prophylactic Cranial Irradiation in Children with Acute Lymphoblastic Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Evaluation of malignant glioma patients during the postirradiation period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Pseudoprogression: Relevance With Respect to Treatment of High-Grade Gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Recurrent high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-013-0228-7

Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index.

21 January 2018

1 reference

12 December 2020

3-Tesla intraoperative MR imaging for neurosurgery

1 reference

12 December 2020

Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy

1 reference

12 December 2020

Risk of astrocytic brain tumors associated with occupational chemical exposures. A case-referent study

1 reference

12 December 2020

Brain tumor mortality risk among men with electrical and electronics jobs: a case-control study

1 reference

12 December 2020

High dose radiation therapy in the treatment of malignant gliomas: Final Report

1 reference

12 December 2020

Current concepts in the pathology and genetics of gliomas

1 reference

12 December 2020

Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989

1 reference

12 December 2020

In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent

1 reference

12 December 2020

Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material

1 reference

12 December 2020

Epilepsy and gliomas: incidence and treatment in 119 patients.

1 reference

12 December 2020

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

12 December 2020

The role of intraoperative magnetic resonance imaging in glioma surgery

1 reference

12 December 2020

10.1007/S11940-013-0228-7

Identifiers

DOI

1 reference

30 November 2017

1 reference